<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 19, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01809002</url>
  </required_header>
  <id_info>
    <org_study_id>ANG-CP-007</org_study_id>
    <nct_id>NCT01809002</nct_id>
  </id_info>
  <brief_title>Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair</brief_title>
  <acronym>RECON</acronym>
  <official_title>A Multicenter, Prospective, Randomized, Subject and Evaluator Blinded Comparative Study of Nerve Cuffs and AvanceÂ® Nerve Graft Evaluating Recovery Outcomes for the Repair of Nerve Discontinuities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AxoGen, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AxoGen, Inc</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Processed Nerve Allograft and Collagen Nerve Cuffs will be compared to assess safety and
      functional outcomes for the repair of nerve injuries in the hand.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Recovery of Static Two Point Discrimination Assessed by Discriminator (in mm)</measure>
    <time_frame>12 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Peripheral Nerve Discontinuities</condition>
  <arm_group>
    <arm_group_label>Processed Nerve Allograft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Processed Nerve Allograft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagen Nerve Cuff</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Processed Nerve Allograft (human)</intervention_name>
    <arm_group_label>Processed Nerve Allograft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Collagen Nerve Cuff</intervention_name>
    <description>Bovine collagen based nerve cuff</description>
    <arm_group_label>Collagen Nerve Cuff</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Peripheral Nerve Injury

        Exclusion Criteria:

          -  Peripheral Neuropathy

          -  Allergic to Bovine products such as Bovine Collagen Nerve Cuff
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan E Isaacs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>L. Scott Levin, MD FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erick DeVinney</last_name>
    <phone>386-362-6829</phone>
    <email>edevinney@axogeninc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>L. Scott Levin, MD FACS</last_name>
    </contact>
    <investigator>
      <last_name>L. Scott Levin, MD FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23228</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jonathan E Isaacs, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jonathan E Isaacs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 8, 2013</lastchanged_date>
  <firstreceived_date>March 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
